Literature DB >> 19365809

Intra-abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer.

Jalid Sehouli1, Filiz Senyuva, Christina Fotopoulou, Ulf Neumann, Carsten Denkert, Lichtenegger Werner, Oskay-Ozcelik Gülten.   

Abstract

INTRODUCTION: We performed a systematic evaluation of tumor pattern and surgical outcome in 214 consecutive patients with primary ovarian cancer.
METHODS: Based on the surgical and histological reports we retrospectively analyzed tumor localizations, surgical and clinical outcome. Cox-regression analysis was performed to identify independent predictors of complete tumor resection and mortality.
RESULTS: Median age was 57.7 years (range: 20-88). FIGO-stage-I was classified in 8.4% and IV in 16.4% of all patients. The peritoneum was the structure most affected (76%) followed by the colon (52%) and diaphragm (44%). Upper abdominal tumor involvement was associated with a significantly higher rate of lymph node metastasis and a significantly lower rate of complete surgical tumor resection, when compared to patients with tumor limited to the lower abdomen. Median overall survival was 56; 61 and 27 months for patients with tumor load in the upper, lower and whole abdomen respectively (P < 0.05).
CONCLUSIONS: The intraoperative tumor dissemination pattern and the post-operative tumor residuals are decisive for the prognosis in primary ovarian cancer. There is an urgent need to use a systematic and standardized tumor documentation protocols to define the predictive and prognostic role of specific tumor pattern and to compare the surgical outcomes of different tumor centers.

Entities:  

Mesh:

Year:  2009        PMID: 19365809     DOI: 10.1002/jso.21288

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  38 in total

1.  Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance.

Authors:  Rachel A Davidowitz; Laura M Selfors; Marcin P Iwanicki; Kevin M Elias; Alison Karst; Huiying Piao; Tan A Ince; Michael G Drage; Judy Dering; Gottfried E Konecny; Ursula Matulonis; Gordon B Mills; Dennis J Slamon; Ronny Drapkin; Joan S Brugge
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

2.  Downregulation of HtrA1 promotes resistance to anoikis and peritoneal dissemination of ovarian cancer cells.

Authors:  Xiaoping He; Takayo Ota; Peng Liu; Changqing Su; Jeremy Chien; Viji Shridhar
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

3.  Factors that influence survival in high-grade serous ovarian cancer: A complex relationship between molecular subtype, disease dissemination, and operability.

Authors:  Diogo Torres; Chen Wang; Amanika Kumar; Jamie N Bakkum-Gamez; Amy L Weaver; Michaela E McGree; Gottfried E Konecny; Ellen L Goode; William A Cliby
Journal:  Gynecol Oncol       Date:  2018-06-18       Impact factor: 5.482

4.  Ovarian cancer development and metastasis.

Authors:  Ernst Lengyel
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

5.  Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells.

Authors:  Jocelyn M Stewart; Patricia A Shaw; Craig Gedye; Marcus Q Bernardini; Benjamin G Neel; Laurie E Ailles
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-30       Impact factor: 11.205

6.  Epithelial Ovarian Cancer and Cancer Stem Cells.

Authors:  Amr A Soliman; Alaa A Elzarkaa; Eduard Malik
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.

Authors:  Peter C Hart; Preety Bajwa; Hilary A Kenny
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Incidental events of diaphragmatic surgery in 82 patients with advanced ovarian, primary peritoneal and fallopian tubal cancer.

Authors:  Fumitoshi Terauchi; Aikou Okamoto; Yumiko Wada; Ei Hasegawa; Toru Sasaki; Osamu Akutagawa; Yasukazu Sagawa; Hirotaka Nishi; Keiichi Isaka
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

Review 9.  The role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer: A Review.

Authors:  Aditi Bhatt; Olivier Glehen
Journal:  Indian J Surg Oncol       Date:  2016-02-16

10.  Intraperitoneal disease dissemination patterns are associated with residual disease, extent of surgery, and molecular subtypes in advanced ovarian cancer.

Authors:  Diogo Torres; Amanika Kumar; Sumer K Wallace; Jamie N Bakkum-Gamez; Gottfried E Konecny; Amy L Weaver; Michaela E McGree; Ellen L Goode; William A Cliby; Chen Wang
Journal:  Gynecol Oncol       Date:  2017-09-28       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.